Companies
Revvity
S&P 500Health Care· USA

RVTY

Balancer

Revvity

$92.64

+3.16%

Open $89.27·Prev $89.80

as of 13 Apr

BALANCER

Power Core

Revvity's moat is its regulatory embeddedness in newborn screening programs, where switching costs are functionally infinite because the cost of failure is dead children.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral Stabilization With Conditional Upward Potential

ROC 200

-7.7%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
RVTY — Revvity — Power Mapping Analysis — L17X — L17X